Inhibition of acetylcholinesterase by two arylderivatives:: 3a-Acetoxy-5H-pyrrolo(1,2-a) (3,1)benzoxazin-1,5-(3aH)-dione and cis-N-p-acetoxy-phenylisomaleimide

被引:16
作者
Correa-Basurto, Jost
Espinosa-Raya, Judith
Gonzalez-May, Mario
Espinoza-Fonseca, L. Michel
Vazquez-Alcantara, Ivan
Trujillo-Ferrara, Jose [1 ]
机构
[1] Escuela Super Med, Secc Estudios Posgrado, Plan San Luis & Diaz Miron, Mexico City 11340, DF, Mexico
[2] Escuela Super Med, Dept Bioquim, Plan San Luis & Diaz Miron, Mexico City 11340, DF, Mexico
[3] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
关键词
AChE; inhibitors; docking; Alzheimer; anilines; arylderivatives; acetylcholinesterase;
D O I
10.1080/14756360500480251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two arylderivatives, 3a-Acetoxy-5H-pyrrolo(1,2-a) (3,1)benzoxazin-l,5-(3aH)-dione 3 and cis-N-p-Acetoxy-phenylisoma-leimide 4, were synthesized from anthranilic acid and para-aminophenol, respectively. The inhibitory effects of these compounds on acetylcholinesterase (AChE) activity were evaluated in vitro as well as by docking simulations. Both compounds showed inhibition of AChE activity (K-i = 4.72 +/- 2.3 mu M for 3 and 3.6 +/- 1.8 mu M for 4) in in vitro studies. Moreover, they behaved as irreversible inhibitors and made pi-pi interaction with W84 and hydrogen bonded with S200 and Y337 according to experimental data and docking calculations. The docking calculations showed Delta G bind (kcal/mol) of - 9.22 for 3 and - 8.58 for 4. These two compounds that can be use as leads for a new family of anti-Alzheimer disease drugs.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 25 条
[1]   SUICIDE ENZYME INACTIVATORS [J].
ABELES, RH ;
MAYCOCK, AL .
ACCOUNTS OF CHEMICAL RESEARCH, 1976, 9 (09) :313-319
[2]  
BALSUBRAMANIYAN V, 1983, TETRAHEDRON, V39, P2487
[3]   Preparation of N-aryl-substituted spiro-β-lactams via Staudinger cycloaddition [J].
Barba, V ;
Hernández, C ;
Rojas-Lima, S ;
Farfán, N ;
Santillan, R .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1999, 77 (12) :2025-2032
[4]   ULTRAMICRO ASSAY OF THE CHOLINESTERASES [J].
BONTING, SL ;
FEATHERSTONE, RM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1956, 61 (01) :89-98
[5]   Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography [J].
Bourne, Y ;
Grassi, J ;
Bougis, PE ;
Marchot, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30370-30376
[6]   Purpuric rash with donepezil treatment [J].
Bryant, CA ;
Ouldred, E ;
Jackson, SHD ;
Kinirons, MT .
BRITISH MEDICAL JOURNAL, 1998, 317 (7161) :787-787
[7]   p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors [J].
Correa-Basurto, J ;
Alcántara, IV ;
Espinoza-Fonseca, LM ;
Trujillo-Ferrara, JG .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (07) :732-735
[8]   Evidence-based pharmacotherapy of Alzheimer's disease [J].
Evans, JG ;
Wilcock, G ;
Birks, J .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (03) :351-369
[9]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[10]   QUATERNARY LIGAND-BINDING TO AROMATIC RESIDUES IN THE ACTIVE-SITE GORGE OF ACETYLCHOLINESTERASE [J].
HAREL, M ;
SCHALK, I ;
EHRETSABATIER, L ;
BOUET, F ;
GOELDNER, M ;
HIRTH, C ;
AXELSEN, PH ;
SILMAN, I ;
SUSSMAN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9031-9035